Institutional Review of Primary Non-Hodgkin Lymphoma of the Female Genital Tract A 33-Year Experience

被引:29
作者
Ahmad, Asima Kaleem [1 ]
Hui, Pei [2 ]
Litkouhi, Babak [3 ]
Azodi, Masoud [2 ]
Rutherford, Thomas [2 ]
McCarthy, Shirley [2 ]
Xu, Mina LuQing [2 ]
Schwartz, Peter E. [2 ]
Ratner, Elena [2 ]
机构
[1] Yale New Haven Med Ctr, New Haven, CT 06504 USA
[2] Yale Univ, Sch Med, New Haven, CT USA
[3] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA
关键词
Pelvic lymphoma; Female genital tract; Non-Hodgkin lymphoma; MALIGNANT-LYMPHOMA; CLINICOPATHOLOGICAL ANALYSIS; PRIMARY MANIFESTATION; OVARIAN TUMOR; REGISTRY; SERIES;
D O I
10.1097/IGC.0000000000000201
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this is to provide an updated review of the literature and to report our institutional experience with this rare gynecologic malignancy. Methods: The medical records of patients with diagnosis of non-Hodgkin lymphoma of the female genital tract from 1980 to 2013 at the Yale-New Haven Hospital were reviewed retrospectively. Histological classification and staging were determined by the World Health Organization and Ann Arbor systems, respectively. Kaplan-Meier was used to calculate the survival. Results: There were 36 patients with diagnosis of non-Hodgkin lymphoma of the female genital tract and followed for a median of 61 months (0-361 months). The median age of diagnosis was 44 years (19-87 years), and 76% (n = 28) were classified as stage IV. Of these, 4 patients were asymptomatic on presentation, and 13 were identified incidentally during surgery/radiography (n = 9), on prenatal ultrasound (n = 1), and on Papanicolaou test (n = 3). The location of the disease included the ovary (n = 6), uterine corpus and cervix (n = 9), vagina (n = 1), a pelvic mass (n = 7), isolated pelvic/para-aortic lymph nodes (n = 3), and/or multiple sites (n = 9). There were 6 cases that were concomitant with other gynecologic malignancies. Diffuse large B-cell lymphoma (n= 18) was the most common histologic type. A total of 28 patients underwent surgery. Combination chemotherapy was used in 34 patients, with concomitant radiation therapy in 7 and stem cell transplantation in 3. A total of 5 patients had recurrent disease. The overall median survival from the diagnosis of lymphoma was 70 months (0.3-361 months) with a 91% 1-year survival, 86% 5-year survival, and a 79% 10-year survival. Conclusions: Our report is the largest published single-institution experience of this disease. It demonstrates a more favorable prognosis and proposes that with early diagnosis and appropriate therapy, radical gynecologic surgery can be avoided.
引用
收藏
页码:1250 / 1255
页数:6
相关论文
共 26 条
[1]  
Armitage J, 2001, NONHODGKINS LYMPHOMA
[2]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[3]   MALIGNANT LYMPHOMA OF CERVIX UTERI - HISTOLOGY AND ULTRASTRUCTURE [J].
CARR, I ;
HILL, AS ;
HANCOCK, B ;
NEAL, FE .
JOURNAL OF CLINICAL PATHOLOGY, 1976, 29 (08) :680-686
[4]  
CHORLTON I, 1974, CANCER, V34, P397, DOI 10.1002/1097-0142(197408)34:2<397::AID-CNCR2820340225>3.0.CO
[5]  
2-0
[6]   Primary ovarian non-Hodgkin's lymphoma: Outcome after treatment with combination chemotherapy [J].
Dimopoulos, MA ;
Daliani, D ;
Pugh, W ;
Gershenson, D ;
Cabanillas, F ;
Sarris, AH .
GYNECOLOGIC ONCOLOGY, 1997, 64 (03) :446-450
[7]  
FERRY JA, 1991, PATHOL ANNU, V26, P227
[8]   MALIGNANT-LYMPHOMA PRESENTING AS AN OVARIAN TUMOR - A CLINICOPATHOLOGICAL ANALYSIS OF 34 CASES [J].
FOX, H ;
LANGLEY, FA ;
GOVAN, ADT ;
HILL, AS ;
BENNETT, MH .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1988, 95 (04) :386-390
[9]  
FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO
[10]  
2-#